Clinical Trials in Spain / NCT06816056
Recruiting Not applicable

Manual Therapy in Hemophilic Arthropathy of the Ankle

NCT06816056 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-02-05
Last updated
2025-02-10

Condition(s) studied

Hemophilia A

Investigational drug(s) / intervention(s)

Manual TherapyPlacebo

Manual Therapy: The patients included in the experimental group will receive a 50-minute physiotherapy intervention involving global passive mobilisation, calcaneocuboid mobilisation, talus-navicular mobilisation, talar manipulation, tibial displacement manipulation, tibiotarsal decompression, plantar fascia induction, tibiotarsal unwinding and triceps surae induction techniques

Placebo: The patients included in the control group will receive a 50-minute physiotherapy intervention in which the physiotherapist's hands and the times per technique will be the same as in the experimental group, but without applying any sliding, mobilisation or manipulation

Study summary

Introduction: Haemophilic ankle arthropathy manifests as functional (deficit in muscle strength, mobility and proprioception), intra-articular degenerative alterations and chronic pain. Manual therapy techniques are characterised by treating the soft tissues with the aim of modifying their density, relieving pain, reducing tissue sensitivity and improving the ranges of mobility. The objective is to evaluate the safety and effectiveness of a manual therapy protocol in patients with haemophilic ankle arthropathy.

Methods: Randomised crossover clinical trial. 13 patients with haemophilic ankle arthropathy from different regions of Spain will be recruited and randomised into two study groups (experimental and control). Each session of the experimental group will last 50 minutes, with 1 physiotherapy session per week for a period of 3 weeks. Patients will be evaluated at the beginning of the study, after the intervention and after a follow-up period of 4 weeks. The treatment programme includes 10 techniques that must be administered bilaterally. The study variables are the frequency of ankle haemarthrosis, range of movement, pressure pain threshold, pain intensity, joint status, biomechanical analysis of gait and balance, functionality and kinesiophobia.

Expected results: To evaluate the safety of manual therapy in patients with haemophilia. To observe changes in pain, mobility, joint condition, stability and functionality of the ankle, and kinesiophobia.

Eligibility

Sex
MALE
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Patients diagnosed with haemophilia A and B * With severe haemophilia phenotype (\<1% FVIII/FIX) * Over 18 years of age * With a medical diagnosis of ankle arthropathy and with clinical assessment using the Hemophilia Joint Health Score * On prophylactic or on-demand treatment with coagulation factor VIII/FIX concentrates Exclusion Criteria: * Patients with neurological or cognitive disorders that prevent them from understanding the questionnaires and physical tests * Failure to sign the informed consent document

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Universidad Católica San Antonio Murcia Spain Recruiting

More Investigación en Hemofilia y Fisioterapia trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06816056 on ClinicalTrials.gov ↗ ← All trials in Spain